GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 414.81
+5.05 (1.23%)
At close: Sep 4, 2025
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 132.10 billion as of September 4, 2025. Its market cap has increased by 205.01% in one year.
Market Cap
132.10B
Enterprise Value
125.94B
Revenue
62.62B
Ranking
n/a
PE Ratio
14.55
Stock Price
414.81
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 132.10B, an increase of 3,403.28%. That is a compound annual growth rate of 12.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 132.10B | 4.51% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | 61.09B | 19.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 112.21B |
| Highnoon Laboratories | 63.05B |
| The Searle Company | 56.28B |
| AGP Limited | 53.77B |
| Shifa International Hospitals | 36.71B |
| Citi Pharma | 21.25B |
| Ferozsons Laboratories | 18.28B |
| Macter International | 18.27B |